Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$4.3 - $7.78 $1,720 - $3,112
400 Added 400.0%
500 $2,000
Q4 2022

Feb 06, 2023

SELL
$5.57 - $11.01 $557 - $1,101
-100 Reduced 50.0%
100 $0
Q2 2022

Jul 19, 2022

BUY
$5.1 - $9.74 $509 - $974
100 Added 100.0%
200 $1,000
Q3 2021

Oct 29, 2021

BUY
$15.75 - $30.29 $1,575 - $3,029
100 New
100 $2,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $123M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.